Glucose Health (OTCMKTS:GLUC) Issues Quarterly Earnings Results

Glucose Health (OTCMKTS:GLUC – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.01) EPS for the quarter, Zacks reports. The business had revenue of $0.05 million during the quarter.

Glucose Health Price Performance

Shares of GLUC remained flat at $0.30 during mid-day trading on Wednesday. 27,300 shares of the stock traded hands, compared to its average volume of 18,329. Glucose Health has a 12-month low of $0.13 and a 12-month high of $0.67. The company has a market capitalization of $8.54 million, a P/E ratio of -10.00 and a beta of 1.30. The firm’s fifty day simple moving average is $0.36 and its 200 day simple moving average is $0.36.

Top Glucose Health Stories

Here are a few of the latest stories about GLUC:

  • Neutral Sentiment: Recent coverage discussed blood-sugar-friendly food choices, diabetes awareness, and patients’ rights over health data. These stories reflect attention to the broader diabetes category but do not report developments specific to Glucose Health. Article: Breakfast swaps to curb blood sugar crashes Article: Charter on diabetes health data
  • Negative Sentiment: Glucose Health reported earnings per share of -$0.01 and quarterly revenue of just $0.05 million. The loss and small revenue base highlight the company’s limited current financial scale and could pressure the stock. Glucose Health company information

About Glucose Health

(Get Free Report)

Glucose Health, Inc. is a consumer health company focused on nutritional products designed to support healthy blood sugar levels. Its principal product is Glucose Health® Blood Sugar Support Drink Mix, a powdered beverage marketed for people seeking a convenient addition to their daily wellness routine. The company’s product is positioned as nutritional support, not as a treatment for diabetes or other medical conditions.

See Also

Earnings History for Glucose Health (OTCMKTS:GLUC)

Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.